Broken redirects

Jump to navigation Jump to search

The following redirects link to non-existent pages:

Showing below up to 500 results in range #1 to #500.

View (previous 500 | ) (20 | 50 | 100 | 250 | 500)

  1. Bangui definition1985 World Health Organization AIDS surveillance case definition
  2. C21-hydroxylase deficiency21-Hydroxylase Deficiency
  3. Steroid 21-hydroxylase deficiency21-Hydroxylase Deficiency
  4. Steroid 21-monooxygenase deficiency21-Hydroxylase Deficiency
  5. MAVErIC II30-Day Results From A Prospective Registry Of Carotid Stenting With The Exponent Stent And Distal Protection With The Guardwire In High Risk Patients
  6. 48,XXYY syndrome48 XX,YY
  7. 48 xxyy syndrome48 XX,YY
  8. ACT-UPAIDS Coalition to Unleash Power
  9. ASTMASTM International
  10. ABSORB: 6-month and 2-year resultsA Bioabsorbable Everolimus-Eluting Coronary Stent System For Patients With Single De-Novo Coronary Artery Lesions
  11. PREPICA Clinical Trial Of Vena Caval Filters In The Prevention Of Pulmonary Embolism In Patients With Proximal Deep-Vein Thrombosis
  12. Comparison of Ibuprofen and Indomethacin for Closure of Patent Ductus ArteriosusA Comparison Of Ibuprofen And Indomethacin For Closure Of Patent Ductus Arteriosus
  13. THESEEA Comparison Of Low-Molecular-Weight Heparin With Unfractionated Heparin For Acute Pulmonary Embolism
  14. TOPASA Comparison Of Recombinant Urokinase With Vascular Surgery As Initial Treatment For Acute Arterial Occlusion Of The Legs
  15. CRISA Controlled Trial Of Verapamil In Patients After Acute Myocardial Infarction: Results Of The Calcium, Antagonist Reinfarction Italian Study
  16. ACCENTA Crohn's Disease Clinical Trial Evaluating Infliximab In A New Long-Term Treatment Regimen
  17. AGENT-3A Multicenter, Prospective, Randomized Trial Of Intracoronary Administration Of Ad5Fgf-4 In Patients With No Revascularization Options
  18. MINTA Multicenter, Randomized Study Of Argatroban Versus Heparin As Adjunct To Tissue Plasminogen Activator (Tpa) In Acute Myocardial Infarction: Myocardial Infarction With Novastan And Tpa (Mint) Study
  19. AMAZEA Multicenter Trial Using-Zestril Versus To Evaluate The Effects On Lowering Blood Pressure
  20. PRIDEA Prospective, Randomized, Controlled Trial Of Distal Protection With The Kensey-Nash Triactiv System Compared To The Guardwire Or Filterwire
  21. CAPTIVEA Prospective, Randomized, Controlled Trial Of Distal Protection With The Third Generation Mednova Emboshield Compared To The Guardwire Or Filterwire
  22. DIABETESA Prospective, Randomized, Controlled Trial Of The Polymer-Based, Sirolimus-Eluting Stent Versus A Bare Metal Stent In Patients With Diabetes Mellitus
  23. AiMIA Prospective, Randomized, Controlled Trial Of Thrombectomy With The Angiojet In Acute Myocardial Infarction
  24. RACTSA Prospective, Randomized Multicenter Trial Of Cilostozal Vs Ticlopidine In Patients Undergoing Stent Implantation
  25. REDUCE IIIA Prospective, Randomized Multicenter Trial Of Cutting Balloon Before Stenting In Patients Undergoing Pci
  26. SYMBIOT IIIA Prospective, Randomized Trial Of A Self-Expanding Ptfe Stent Graft During Svg Intervention - Late Results
  27. SYNERGY-PCIA Prospective, Randomized Trial Of Enoxaparin And Unfractionated Heparin In Patients With Acute Coronary Syndromes - Results In Patients Undergoing Percutaneous Coronary Intervention
  28. GENESISA Randomized, Multicenter Study Of The Pimecrolimus-Eluting And Pimecrolimus/Paclitaxel-Eluting Coronary Stent System In Patients With De Novo Lesions Of The Native Coronary Arteries
  29. RAVELA Randomized Comparison Of A Sirolimus-Eluting Stent With A Standard Stent For Coronary Revascularization
  30. GENIUS-STEMIA Randomized Comparison Of Genous Stent Versus Chromium-Cobalt Stent For Treatment Of St-Elevation Myocardial Infarction
  31. DES-DIABETESA Randomized Comparison Of Sirolimus- Versus Paclitaxel-Eluting Stent Implantation In Patients With Diabetes Mellitus
  32. ADVANCEA Randomized Comparison Of The Value Of Additional Stenting After Optimal Balloon Angioplasty For Long Coronary Lesions
  33. RIO-EuropeA Randomized Double-Blind Study Of Weight Reducing Effect And Safety Of Rimonabant In Obese Patients With Or Without Comorbidities
  34. SPIRITA Randomized Trial Of Anticoagulants Versus Aspirin After Cerebral Ischemia Of Presumed Arterial Origin
  35. STARA Randomized Trial Of Recombinant Staphylokinase Versus Altepase For Coronary Artery Patency In Acute Myocardial Infarction
  36. SMARTTA Randomized Trial Of The Effects Of Early Cardiac Serum Marker Availability On Reperfusion Therapy In Patients With Acute Myocardial Infarction. The Serial Markers, Acute Myocardial Infarction And Rapid Treatment Trial (Smartt)
  37. INTERHEARTA Study Of Risk Factors For First Myocardial Infarction In 52 Countries And Over 27,000 Subjects
  38. ASTEROIDA Study To Evaluate The Effect Of Rosuvastatin On Intravascular Ultrasound-Derived Coronary Atheroma Burden
  39. AURORAA Study To Evaluate The Use Of Rosuvastatin In Subjects On Regular Hemodialysis: An Assessment Of Survival And Cardiovascular Events
  40. TubulidentataAardvark
  41. Aaron BeckAaron Temkin Beck
  42. AbESTTAbciximab Emergent Stroke Treatment Trial
  43. APAFAblation For Paroxysmal Atrial Fibrillation (Apaf) Trial
  44. Abraham De MoivreAbraham de Moivre
  45. AbulcasisAbu al-Qasim al-Zahrawi
  46. Al-ZahrawiAbu al-Qasim al-Zahrawi
  47. ACTIVATEAcat Inhibition On The Progression Of Coronary Atherosclerosis
  48. Access Site ComplicationsAccess site complications
  49. ASTRONAUTAcid Suppression Trial: Ranitidine Zantac Versus Omeprazole
  50. Acinetobacter sppAcinetobacter
  51. ATLAS - SVGAcolysis During Treatment Of Lesions Affecting Saphenous Vein Bypass Grafts
  52. Acquired pure megakaryocytic aplasiaAcquired pure red cell aplasia
  53. ASCENTAcs Stent Clinical Equivalence In De Novo Lesions Trial
  54. ACTIV in CHFAcute And Chronic Therapeutic Impact Of A Vasopressin 2 Antagonist (Tolvaptan) In Congestive Heart Failure
  55. ACCESSAcute Candesartan Cilexetil Evaluation In Stroke Survivors
  56. ACUITY Timing TrialAcute Catheterization And Urgent Intervention Triage Strategy Timing Trial
  57. ACUITY PCI: 30-day and 1-Year ResultsAcute Catheterization And Urgent Intervention Triage Strategy Trial - Pci Subgroup: 30-Day And 1-Year Results
  58. AIREAcute Infarction Ramipril Efficacy Study
  59. AIST-ASHAcute Ischemic Stroke Trial: Oral Aspirin Vs Intravenous Heparin On Stroke Progression
  60. AMISTADAcute Myocardial Infarction Study Of Adenosine
  61. AMISTAD IIAcute Myocardial Infarction Study Of Adenosine II
  62. AMISTAD IAcute Myocardial Infarction Study Of Adenosine Trial
  63. AMIHOTAcute Myocardial Infarction With Hyperoxemic Therapy
  64. AMIHOT IIAcute Myocardial Infarction With Hyperoxemic Therapy II
  65. Acute biphenotypic leukemiaAcute biphenotypic leukaemia
  66. FEMINAAddition Of Felodipine To Metoprolol Vs. Replacement Of Metoprolol By Felodipine In Patients With Angina Pectoris Despite Adequate Beta-Blockade
  67. Adenoid cystic cancerAdenoid cystic carcinoma
  68. AdenocystAdenoid cystic carcinoma
  69. Malignant cylindromaAdenoid cystic carcinoma
  70. Adenocystic carcinomaAdenoid cystic carcinoma
  71. Adenoidcystic carcinomaAdenoid cystic carcinoma
  72. Cribriform CarcinomaAdenoid cystic carcinoma
  73. Toxic thyroid adenomaAdenoma of the thyroid
  74. INSPIREAdenosine Sestamibi Post-Infarction Evaluation (Inspire) Trial
  75. ADEMEXAdequacy Of Peritoneal Dialysis In Mexico
  76. ABACASAdjunctive Balloon Angioplasty Following Coronary Atherectomy Study
  77. Adolf WindausAdolf Otto Reinhold Windaus
  78. Adrien Marie LegendreAdrien-Marie Legendre
  79. AGISAdvanced Glaucoma Intervention Study
  80. AdvocacyAdvocate
  81. AIRAerosolized Iloprost Randomized Placebo-Controlled Study
  82. A-HeFTAfrican-American Heart Failure Trial
  83. A to Z, Phase AAggrastat To Zocor
  84. AtoZAggrastat To Zocor Study
  85. AggressivenessAggression
  86. ALLIANCEAggressive Lipid-Lowering Initiation Abates New Cardiac Events
  87. ARISEAggressive Reduction Of Inflammation Stops Events
  88. Intermediate-grade lymphomaAggressive lymphoma
  89. High-grade lymphomaAggressive lymphoma
  90. Aging in PlaceAging in place
  91. Redtop grassAgrostis gigantea
  92. Alcoholic beveragesAlcoholic beverage
  93. Aldactone AntagonistsAldactone antagonist
  94. LemtradaAlentuzumab
  95. Immortality DeviceAlex Chiu
  96. Edmé Félix Alfred VulpianAlfred Vulpian
  97. ALLAYAliskiren In Left Ventricular Hypertrophy
  98. AVOIDAliskiren In The Evaluation Of Proteinuria In Diabetes
  99. ALOFTAliskiren Observations Of Heart Failure Treatment
  100. ATBCAlpha-Tocopherol, Beta-Carotene Lung Cancer Prevention Study
  101. AlphaPharmAlphapharm
  102. ATLANTISAlteplase Thrombolysis For Acute Noninterventional Therapy In Ischemic Stroke
  103. ABCDAlternans Before Cardioverter Defibrillator
  104. AEGISAlternative Graft Investigational Study
  105. ADCSAlzheimer's Disease Cooperative Study
  106. ARIES 1 and 2Ambrisentan In Pulmonary Arterial Hypertension Efficacy Study 1 And 2
  107. AAFPAmerican Academy of Family Physicians
  108. ACC AMI GAPAmerican College Of Cardiology Acute Myocardial Infarction Guidelines Applied To Practice Study
  109. Journal of the American College of CardiologyAmerican College of Cardiology
  110. ACCAmerican College of Cardiology
  111. J. Am. Med. Assoc.American Medical Association
  112. Amiodarone overdoseAmiodaroneI#Overdosage
  113. ALIVE (amio vs. lidocaineAmiodarone As Compared With Lidocaine For Shock-Resistant Ventricular Fibrillation
  114. ARCHAmiodarone Reduction In Coronary Heart Trial
  115. AMIOVIRTAmiodarone Versus Implantable Defibrillator In Patients With Nonischemic Cardiomyopathy And Asymptomatic Nonsustained Ventricular Tachycardia Study
  116. AMROAmsterdam-Rotterdam Trial
  117. Amyotrophic lateral sclerosis diagnostic evaluationAmyotrophic lateral sclerosis other diagnostic studies
  118. Anal-oral contactAnal-oral sex
  119. Anal intercourseAnal sex
  120. Andersen cardiodysrhythmic periodic paralysisAndersen–Tawil syndrome
  121. Andreas GrüntzigAndreas Gruentzig
  122. Andrew Z. FireAndrew Fire
  123. AndrogyneAndrogyny#Androgyne
  124. AndrogynousAndrogyny
  125. Andre Frederic CournandAndré Frédéric Cournand
  126. Andre MalrauxAndré Malraux
  127. André LwoffAndré Michel Lwoff
  128. Andre LwoffAndré Michel Lwoff
  129. ASISAngina And Silent Ischemia Study
  130. ATLANTICAngina Treatments - - Lasers And Normal Therapies In Comparison
  131. AWESOMEAngina With Extremely Serious Operative Mortality Evaluation
  132. AGENTAngiogenic Gene Therapy
  133. AGENT-2Angiogenic Gene Therapy Trial 2
  134. STARCAngioplasty/Atherectomy/Laser Therapy: Trapidil (Triazolopyrimidine), A Platelet-Derived Growth Factor Antagonist, Reduces Restenosis After Percutaneous Transluminal Coronary Angioplasty: Results Of The Randomized, Double-Blind Starc Study
  135. ASTRALAngioplasty And Stenting For Renal Artery Lesions
  136. ACMEAngioplasty Compared To Medicine
  137. ACME-2Angioplasty Compared To Medicine - Two-Vessel Disease
  138. ARTISTAngioplasty Versus Rotational Atherectomy For Treatment Of Diffuse In-Stent Restenosis Trial
  139. ARTISTICAngiorad Radiation Therapy For In-Stent Restenosis Intracoronary
  140. APRESAngiotensin-Converting Enzyme Inhibition Post Revascularization Study
  141. AACHENAngiotensin II Receptor Blocker Candesartan Cilexetil On Intimal Hyperplasia After Coronary Stent Implantation
  142. ASCOTAnglo-Scandinavian Cardiac Outcome Trial
  143. ASCOT - Blood Pressure ArmAnglo-Scandinavian Cardiac Outcomes Trial: Blood Pressure-Lowering Arm
  144. ASSETAnglo-Scandinavian Study Of Early Thrombolysis
  145. Vessel tortuosityAngulation and tortuosity
  146. Tortuous vesselAngulation and tortuosity
  147. AnimalsAnimal
  148. AnimaliaAnimal
  149. MetazoaAnimal
  150. Anthrax Vaccine AdsorbedAnthrax vaccine
  151. Anthrax vaccine adsorbedAnthrax vaccine
  152. AVAAnthrax vaccine
  153. APLAUSEAnti-Platelet Treatment After Intravascular Ultrasound Guided Optimal Stent Expansion
  154. ATTACHAnti-Tnf Therapy Against Congestive Heart Failure Trial
  155. ATTRACTAnti-Tnf Trial In Rheumatoid Arthritis With Ca2 Treatment
  156. ATLAS-TIMI 46Anti-Xa Therapy To Lower Cardiovascular Events In Addition To Aspirin With Or Without Thienopyridine In Subjects With Acute Coronary Syndromes–Thrombolysis In Myocardial Infarction 46
  157. ADIOSAntiarrhythmic Drug Improve Outcome Study
  158. ANTIBIOAntibiotic Therapy After An Acute Myocardial Infarction
  159. ATBATAnticoagulant Therapy With Bivalirudin To Assist In Pci 1St Inning Trial (Pci In Hit/Hitts)
  160. ANTHEM–TIMI-32Anticoagulation With Rnapc2 To Eliminate Mace/Timi 32
  161. ATICHAntifibrinolytic Therapy In Acute Intracerebral Hemorrhage
  162. APASSAntiphospholipid Antibody Stroke Study
  163. ATLASTAntiplatelet Therapy Alone Versus Lovenox Plus Antiplatelet Therapy In Patients At Increased Risk Of Stent Thrombosis
  164. ARMYDA-RELOADAntiplatelet Therapy For Reduction Of Myocardial Damage During Angioplasty-Reload
  165. ARMYDA-2Antiplatelet Therapy For Reduction Of Myocardial Damage During Angioplasty 2
  166. ARMYDA-3Antiplatelet Therapy For Reduction Of Myocardial Damage During Angioplasty 3
  167. ARMYDA-4Antiplatelet Therapy For Reduction Of Myocardial Damage During Angioplasty 4
  168. ARMYDA-5Antiplatelet Therapy For Reduction Of Myocardial Damage During Angioplasty 5
  169. STAIAntiplatelet Treatment With Ticlopidine In Unstable Angina (Studio Della Ticlopidine Nell'Angina Instabile)
  170. AT LASTAntiretroviral Trial Looking At Sex And Treatment
  171. APRICOTAntithrombotics In The Prevention Of Reocclusion In Coronary Thrombolysis
  172. APRICOT-2Antithrombotics In The Prevention Of Reocclusion In Coronary Thrombolysis-2
  173. LavoisierAntoine Lavoisier
  174. Anton van LeeuwenhoekAntonie van Leeuwenhoek
  175. Antoine van LeeuwenhoekAntonie van Leeuwenhoek
  176. Antonio Caetano De Abreu Freire Egas MonizAntónio Egas Moniz
  177. Hysterical neurosisAnxiety disorder
  178. Anxiety-tension syndromeAnxiety disorder
  179. ASSERTAortic Stentless Versus Stented Valve Assessed By Echocardiography Randomized Trial
  180. ACREAppropriateness Of Coronary Revascularization
  181. AIMSApsac Intervention Mortality Study
  182. ARMSApsac Reocclusion Multicenter Study
  183. ALKKArbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte
  184. ARG-911Argatroban-911
  185. ARG-915Argatroban-915
  186. ARGAMI-2Argatroban For Acute Myocardial Infarction
  187. ERACI IIArgentine Randomized Study: Coronary Angioplasty With Stenting Vs. Coronary Artery Bypass Surgery In Patients With Multiple-Vessel Disease (Eraci II): 30-Day And One Year Follow-Up Results
  188. ATACArimidex (Anastrozole), Tamoxifen And Combination Therapy
  189. ASPIREArixtra Study In Percutaneous Coronary Intervention: A Randomized Evaluation
  190. AFREGSArmed Forces Regression Study
  191. Army Nurse Corps (United States)Army Medical Department (United States)#Army Nurse Corps
  192. ASSUREArrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit Of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter Defibrillator Implantations
  193. MugwortArtemisia vulgaris
  194. Mugwort treeArtemisia vulgaris
  195. ARBITER 2Arterial Biology For The Investigation Of The Treatment Effects Of Reducing Cholesterol 2
  196. ADMITArterial Disease Multiple Intervention Trial
  197. ARTSArterial Revascularization Therapies Study
  198. ARTS-IIArterial Revascularization Therapies Study Part II: Sirolimus-Eluting Stents For The Treatment Of Patients With Multivessel De Novo Coronary Artery Lesions
  199. Arthritis echocardiography or ultrasoundArthritis ultrasound
  200. Arthritis chest x rayArthritis x ray
  201. ACE (Carotid Endarterectomy)Asa And Carotid Endarterectomy Trial
  202. AsklepiosAsclepius
  203. ALTSAscus/Lsil Triage Study
  204. Aseptic meningitis laboratory testsAseptic meningitis laboratory findings
  205. AsexualAsexuality
  206. ASPACAsian-Pacific Collaboration On Chd Risk Factor Intervention
  207. ErwinazeAsparaginase Erwinia Chrysanthemi
  208. ASPECT-2Aspirin And Coumadin After Acute Coronary Syndromes (The Aspect-2) Study: A Randomised Controlled Trial.
  209. ADONISAspirin Dose Optimized In Noncardioembolic Ischemic Stroke
  210. AVASISAspirin Versus Anticoagulants In Symptomatic Intracranial Stenosis
  211. ACCURACYAssessment By Coronary Computed Tomographic Angiography Of Individuals Undergoing Invasive Coronary Angiography
  212. ACORNAssessment Of A Cardiac Support Device (Csd) In Patients With Heart Failure
  213. ACUTEAssessment Of Cardioversion Using Transesophageal Echocardiography
  214. ACUTE IIAssessment Of Cardioversion Using Transesophageal Echocardiography
  215. ADVENTAssessment Of Diabetes Control And Evaluation Of The Efficacy Of Niaspan Trial
  216. ASSISTAssessment Of Implementation Strategies
  217. ALERTAssessment Of Lescol In Renal Transplantation
  218. APEX AMIAssessment Of Pexelizumab In Acute Myocardial Infarction
  219. ALBIONAssessment Of The Best Loading Dose Of Clopidogrel To Blunt Platelet Activation, Inflammation, And On-Going Necrosis
  220. AMEthystAssessment Of The Medtronic Ave Interceptor Saphenous Vein Graft Filter System
  221. ASSENT-2Assessment Of The Safety And Efficacy Of A New Thrombolytic: Tnk-Tpa-2
  222. ASSENT 3 PLUSAssessment Of The Safety And Efficacy Of A New Thrombolytic Regimen-3
  223. ASSENT-4 PCIAssessment Of The Safety And Efficacy Of A New Treatment Strategy For Acute Myocardial Infarction
  224. ASSENT-1Assessment Of The Safety Of A New Thrombolytic: Tnk-Tpa
  225. ATLASAssessment Of Treatment With Lisinopril And Survival
  226. APPROACHAssessment On The Prevention Of Progression By Rosiglitazone On Atherosclerosis In Diabetes Patients With Cardiovascular History
  227. Assessment of Severity of MSAssessment of severity of Mitral stenosis
  228. ABC studyAssociation Of Black Cardiologists Study Of Hypertension
  229. AAMIAssociation for the Advancement of Medical Instrumentation
  230. ASTAMIAstami
  231. Sir Astley Paston CooperAstley Cooper
  232. Astrocytoma other imaging findingsAstrocytoma imaging findings
  233. ACIPAsymptomatic Cardiac Ischemia Pilot Study
  234. ACASAsymptomatic Carotid Atherosclerosis Study
  235. ACSTAsymptomatic Carotid Surgery Trial
  236. ASFASTAtherosclerosis And Folic Acid Supplementation Trial
  237. ARICAtherosclerosis Risk In Communities
  238. C-PORTAtlantic Cardiovascular Patient Outcomes Research Team Trial
  239. ARMYDAAtorvastatin For Reduction Of Myocardial Damage During Angioplasty
  240. ARMYDA-ACSAtorvastatin For Reduction Of Myocardial Damage During Angioplasty-Acute Coronary Syndromes
  241. ARMYDA-RECAPTUREAtorvastatin For Reduction Of Myocardial Damage During Angioplasty-Recapture
  242. ATHEROMAAtorvastatin Therapy: Effects Of Reduction Of Macrophage Activity
  243. ADOPTAtrial Dynamic Overdrive Pacing Trial
  244. ADOPT-AAtrial Dynamic Overdrive Pacing Trial-A
  245. AFASAKAtrial Fibrillation, Aspirin, Antikoagulation
  246. AF-CHFAtrial Fibrillation And Congestive Heart Failure
  247. AFFIRMAtrial Fibrillation Follow-Up Investigation Of Rhythm Management
  248. ASTRIDAtrial Sensing Trial To Prevent Inappropriate Detections
  249. ATTESTAtrial Therapy Efficacy And Safety Trial
  250. Schack August Steenberg KroghAugust Krogh
  251. Augustus WallerAugustus Volney Waller
  252. ANZ-CarvedilolAustralia-New Zealand Heart Failure Research Collaborative Group Carvedilol Trial
  253. ANBP2Australian National Blood Pressure Study Group
  254. ASTISAutologous Stem Cell Transplantation International Scleroderma Trial
  255. IBVAvian infectious bronchitis virus
  256. Ibn SinaAvicenna
  257. Abū Alī ibn SīnāAvicenna
  258. Self-awarenessAwareness#Self-awareness
  259. A-COMET-IAzimilide—Cardioversion Maintenance Trial–I
  260. A-COMET-IIAzimilide—Cardioversion Maintenance Trial–II
  261. AZACSAzithromycin In Acute Coronary Syndrome
  262. ACADEMICAzithromycin In Coronary Artery Disease: Elimination Of Myocardial Infection With Chlamydia
  263. BACHBach
  264. Back pain echocardiography or ultrasoundBack pain ultrasound
  265. BOATBalloon Angioplasty Versus Optimal Atherectomy Trial
  266. BPAVBalloon Prophylaxis Of Aneurysmal Vasospasm
  267. ATRAMIBaroreflex Sensitivity And Heart-Rate Variability In Prediction Of Total Cardiac Mortality After Myocardial Infarction. Atrami (Autonomic Tone And Reflexes After Myocardial Infarction) Investigators.
  268. Barry J. MarshallBarry Marshall
  269. BASISBasel Antiarrhythmic Study Of Infarct Survival
  270. BASKETBasel Stent Cost-Effectiveness Trial
  271. BRILLIANTBatimastat (Bb-94) Antirestenosis Trial Utilizing The Biodivysio Local Drug Delivery Pc Stent
  272. BRAVEBavarian Reperfusion Alternatives Evaluation
  273. BRAINSBayer Randomized Acute Ischemia Neuroprotectant Study
  274. BeansBean
  275. BARSBeaumont Alcohol Restenosis Study
  276. BeclometasoneBeclometasone dipropionate
  277. VancerilBeclometasone dipropionate
  278. Beet JuiceBeet
  279. Scribner shuntBelding H. Scribner
  280. BENESTENT IBelgian-Netherlands Stent Study (I)
  281. BENESTENT IIBelgian-Netherlands Stent Study II (Pilot)
  282. BENEDICTBergamo Nephrologic Diabetes Complications Tria
  283. BESSAMIBerlin Stent Study In Acute Myocardial Infarction
  284. Bernardo Alberto HoussayBernardo Houssay
  285. BBS—Cognitive StudyBest Bypass Surgery—Cognitive Study
  286. BESMARTBestent In Small Arteries Trial
  287. BCAPSBeta-Blocker Cholesterol-Lowering Asymptomatic Plaque Study
  288. BEST-ICDBeta-Blocker Evaluation Of Survival Trial Plus Icd
  289. BICCBeta-Interferon In Chronic Viral Cardiomyopathy
  290. BRIDGEBeta-Radiation Investigation With Direct Stenting And Galileo In Europe
  291. Dialysis related amyloidosisBeta2-microglobulin related amyloidosis
  292. Beta2-microglobulin amyloidosisBeta2-microglobulin related amyloidosis
  293. Beta 2 microglobulin related amyloidosisBeta2-microglobulin related amyloidosis
  294. Beta 2 amyloidosisBeta2-microglobulin related amyloidosis
  295. Amyloidosis due to B2 micrglobulinBeta2-microglobulin related amyloidosis
  296. B2 microglobulin amyloidosisBeta2-microglobulin related amyloidosis
  297. Β2-microglobulin-related amyloidosisBeta2-microglobulin related amyloidosis
  298. Beta-1 receptorsBeta 1 adrenergic receptor
  299. BESTBeta Blocker Evaluation Of Survival Trial
  300. BHATBeta Blocker Heart Attack Trial
  301. BLOSSBeta Blocker Length Of Stay Study
  302. BERTBeta Energy Restenosis Trial - 1
  303. BRIEBeta Radiation In Europe
  304. BRITEBeta Radiation To Reduce In-Stent Restenosis
  305. BRITE IIBeta Radiation To Reduce In-Stent Restenosis II
  306. BRITE-SVGBeta Radiation To Reduce In-Stent Restenosis In Saphenous Vein Grafts
  307. BETTERBeta Radiation Trial To Eliminate Restenosis
  308. BENEFITBetaferon (Betaseron In U.S.) In Newly Emerging Ms For Initial Treatment Information
  309. Betamethasone sodium phosphateBetamethasone sodium phosphate (injection)
  310. BRAVE-2Beyond 12 Hours Reperfusion Alternative Evaluation Trial
  311. BELLESBeyond Endorsed Lipid Lowering With Ebt Scanning
  312. BECAITBezafibrate Coronary Atherosclerosis Intervention Trial
  313. BIPBezafibrate Infarction Prevention Study
  314. BATMANBiodivysio 'Bat'Imastat Sv Stent Versus Balloon Angioplasty For The Reduction Of Restenosis In Small Coronary Arteries
  315. DISTINCTBiodivysio Stent In Controlled Trial
  316. Biovail CorporationBiovail
  317. BiCardBiphasic Vs. Monophasic Shock Waveform For Conversion Of Atrial Fibrillation. The Results Of An International Randomized, Double-Blind Multicenter Trial
  318. BATBivalirudin Angioplasty Study
  319. ISAR-REACT 3Bivalirudin Versus Unfractionated Heparin During Percutaneous Coronary Intervention
  320. PAVEBiventricular Pacing After Ablate Compared With Right Ventricular Therapy
  321. BackgroundBleeding background
  322. Bleeding:MiscellaneousBleeding miscellaneous
  323. BLIND-DATEBlinded Withdrawal Of Deprenyl In The Datatop Extension Trial
  324. BASCBlood Pressure In Acute Stroke Collaboration
  325. Boehringer IngelheimBoehringer-Ingelheim
  326. BogalusaBogalusa Heart Study
  327. BIRDBolus Versus Infusion In Rescupase (Saruplase) Development
  328. BOOSTBone Marrow Transfer To Enhance St-Elevation Infarct Regeneration
  329. Encephalopathy - intracerebral calcification - retinal degenerationBonneman-Meinecke-Reich syndrome
  330. Boots the ChemistBoots Group
  331. BREATHE-1Bosentan (Tracleer): Randomized Trial Of Endothelin Receptor Antagonist Therapy For Pulmonary Hypertension
  332. BENEFiTBosentan Effects In Inoperable Forms Of Chronic Thromboembolic Pulmonary Hypertension
  333. BAATAFBoston Area Anticoagulation Trial For Atrial Fibrillation
  334. BEACHBoston Scientific Epi: A Carotid Stenting Trial For High-Risk Surgical Patients
  335. Envenomization by bothrops lanceolatusBothrops lanceolatus
  336. Envenomization by the Martinique lancehead viperBothrops lanceolatus
  337. BASELBrain Natriuretic Peptide For Acute Shortness Of Breath Evaluation: A Randomized Comparison
  338. CAKE (drug)Brass Eye
  339. Soma (Brave New World)Brave New World
  340. BCPTBreast Cancer Prevention Trial
  341. Brenner tumourBrenner tumor
  342. Brenner tumor of ovaryBrenner tumor
  343. Brenner tumor of the ovaryBrenner tumor
  344. Transitional cell tumour of the ovaryBrenner tumor
  345. Ovarian transitional cell tumourBrenner tumor
  346. BRIEF-PCIBrief Infusion Of Eptifibatide Following Percutaneous Coronary Intervention
  347. BBC ONEBritish Bifurcation Coronary Study: Old, New, And Evolving Strategies
  348. Bronchial Glad CarcinomasBronchial gland carcinomas
  349. Brown recluseBrown recluse spider
  350. Buchu Leaf OilBuchu
  351. BEATBucindolol Evaluation In Acute Myocardial Infarction Trial
  352. Su vegetarianismBuddhist vegetarianism
  353. wikidoc:Build the webBuild the web
  354. Bulk flowBulk movement
  355. BARI 2DBypass Angioplasty Revascularization Investigation In Type 2 Diabetics
  356. FIGFC-fos induced growth factor
  357. Pulmonary Disorders and COVID-19COVID-19 Pulmonary Complications
  358. COVID-19 Pulmonary disordersCOVID-19 Pulmonary Complications
  359. Coronavirus Pulmonary disordersCOVID-19 Pulmonary Complications
  360. Covid 19 pulmonologyCOVID-19 Pulmonary Complications
  361. COVID-19 pulmonologyCOVID-19 Pulmonary Complications
  362. COVID lungCOVID-19 Pulmonary Complications
  363. Cesium hydroxideCaesium hydroxide
  364. CASTEMICalderet In St Elevation Myocardial Infarction
  365. Calibration (probability)Calibrated probability assessment
  366. C. R. RaoCalyampudi Radhakrishna Rao
  367. Camille GuerinCamille Guérin
  368. PRIMA — Presented at ACC.09/i2Can Pro-Brain Natriuretic Peptide Guided Therapy Of Heart Failure Improve Heart Failure Morbidity And Mortality?
  369. CRUISECan Routine Ultrasound Influence Stent Expansion
  370. CAESARCanada, Australia, Europe, South Africa Aids Study
  371. CASESCanadian Activase For Stroke Effectiveness Study
  372. CAMIATCanadian Amiodarone Myocardial Infarction Arrhythmia Trial (Pilot)
  373. CASISCanadian Amlodipine/Atenolol In Silent Ischemia Study
  374. CARTCanadian Antioxidant Restenosis Trial
  375. CAFACanadian Atrial Fibrillation Anticoagulation Study
  376. CREATECanadian Cardiac Randomized Evaluation Of Antidepressant And Psychotherapy Efficacy
  377. CCATCanadian Coronary Atherectomy Trial
  378. CIDSCanadian Implantable Defibrillator Study
  379. C-SIRIUSCanadian Sirolimus-Eluting Stent In Coronary Lesions
  380. CTAFCanadian Trial Of Atrial Fibrillation
  381. CTOPPCanadian Trial Of Physiologic Pacing
  382. CASTLECandesartan Amlodipine Study Of Tolerability And Efficacy
  383. CALMCandesartan And Lisinopril Microalbuminuria Study
  384. CHARMCandesartan Cilexitil (Atacand) In Heart Failure Assessment Of Reduction Mortality And Morbidity
  385. CHARM Added TrialCandesartan In Heart Failure—Added Trial
  386. CHARM Alternative TrialCandesartan In Heart Failure—Alternative Trial
  387. CHARM Overall Programme ResultsCandesartan In Heart Failure—Assessment Of Reduction In Mortality And Morbidity
  388. CHARM Preserved TrialCandesartan In Heart Failure—Preserved Trial
  389. CANDLECandesartan Versus Losartan Efficacy Comparison
  390. Vulvovaginal CandidosisCandida Vulvovaginitis
  391. Cangrelor during PCICangrelor During Percutaneous Coronary Intervention
  392. Canine distemper virusCanine distemper
  393. CAPTENCaptopril After Thrombolysis Trial
  394. CAPTINCaptopril Plus Tissue Plasminogen Activator Following Acute Myocardial Infarction
  395. CAPPPCaptopril Prevention Project
  396. CASCADECardiac Arrest In Seattle: Conventional Versus Amiodarone Drug Evaluation Study
  397. CASHCardiac Arrest Study-Hamburg
  398. CASTCardiac Arrhythmia Suppression Trial
  399. CIBISCardiac Insufficiency Bisoprolol Study
  400. CARE-HFCardiac Resynchronization - Heart Failure European Complement To U.S./Canada Miracle Study
  401. Amylodosis of the heartCardiac amylodosis
  402. The heart in amyloidosisCardiac amylodosis
  403. Acute myocardial injury in covid-19Cardiac complications of COVID-19#acute myocardial injury
  404. Cardiac tamponade complicationsCardiac tamponade natural history
  405. Cardiac tamponade prognosisCardiac tamponade natural history
  406. CHSCardiovascular Health Study
  407. COOLCardiovascular Thrombolytic To Open Occluded Lines
  408. Carl RokitanskyCarl Freiherr von Rokitansky
  409. Carl von RokitanskyCarl Freiherr von Rokitansky
  410. LinnaeusCarl Linnaeus
  411. Karl WernickeCarl Wernicke
  412. Carbolic Smoke BallCarlill v. Carbolic Smoke Ball Company
  413. CAPTURE RegistryCarotid Acculink/Accunet Post-Approval Trial To Uncover Unanticipated Or Rare Events Registry
  414. CAPTIVATECarotid Atherosclerosis Progression Trial Investigating Vascular Acat Inhibition Treatment Effects
  415. CHICAGOCarotid Intima-Media Thickness In Atherosclerosis Using Pioglitazone
  416. COSSCarotid Occlusion Surgery Study
  417. EUROCARECarvedilol For Prevention Of Restenosis After Directional Coronary Atherectomy
  418. CHRISTMASCarvedilol Hibernating Reversible Ischaemia Trial
  419. CARIBECarvedilol Insuficiencia Cardiaca (Heart Failure) Beta-Receptor
  420. COLACarvedilol Open Label Assessment
  421. COMETCarvedilol Or Metoprolol European Trial
  422. Kazimierz FunkCasimir Funk
  423. CACAFCatheter Ablation For The Cure Of Atrial Fibrillation Study
  424. A4 StudyCatheter Ablation Versus Antiarrhythmic Drugs For Atrial Fibrillation
  425. Cauchy-Schwarz inequalityCauchy–Schwarz inequality
  426. CLASSCelecoxib (Celebrex) Long-Term Arthritis Safety Study
  427. User talk:Laurarobert23Cellulite Removal
  428. CBERCenter for Biologics Evaluation and Research
  429. CDRHCenter for Devices and Radiological Health
  430. Central Limit TheoremCentral limit theorem
  431. CEPCep
  432. GrainCereal
  433. CerealsCereal
  434. CAMEOCerebral Aneurysm Multicenter European
  435. Cerebrotendinous XanthomatosusCerebrotendinous xanthomatosis
  436. Van Bogaert diseaseCerebrotendinous xanthomatosis
  437. Charles Herbert BestCharles Best
  438. Charles B. HugginsCharles Brenton Huggins
  439. DarwinCharles Darwin
  440. Charles Frederic GerhardtCharles Frédéric Gerhardt
  441. Charles S. PeirceCharles Peirce
  442. Charles DrewCharles R. Drew
  443. Charles DotterCharles Theodore Dotter
  444. Chernobyl accidentChernobyl disaster
  445. Child careChildcare
  446. CAPTUREChimeric 7E3 Antiplatelet Therapy In Unstable Angina Refractory To Standard Treatment
  447. CSSSChina Salt Substitute Study
  448. CCS-1Chinese Cardiac Study
  449. Food therapyChinese food therapy
  450. Chiron Corp.Chiron Corporation
  451. User talk:Drsjpdc/Sandbox1d-HxChiropractic - HIstory
  452. Chloramphenicol sodium succinateChloramphenicol succinate
  453. Chokenflok SyndromeChokenflok syndrome
  454. CLARIDICholesterol Lowering And Arrhythmias Recurrences After Internal Defibrillator Implantation
  455. CLAS I AND IICholesterol Lowering Atherosclerosis Study (I And II)
  456. ChordatesChordate
  457. Papilloma of the choroid plexusChoroid plexus papilloma and carcinoma
  458. CORSICAChronic Occlusion Revascularization With Stent Implantation Versus Coronary Angioplasty
  459. Chronic Stable Angina EpidemiologyChronic stable angina epidemiology
  460. Chronic stable angina ACC/AHA guidelines for revascularizationChronic stable angina guidelines for revascularization to improve prognosis and reduce symptoms
  461. Chronic Stable Angina Clinical PresentationChronic stable angina symptoms
  462. Chronic stable angina clinical presentationChronic stable angina symptoms
  463. TOChronic total occlusions treatment
  464. Chronic TOChronic total occlusions treatment
  465. Chronic total occlusionChronic total occlusions treatment
  466. PCI in the Patient with a Chronic Total OcclusionChronic total occlusions treatment
  467. Treatment of Chronic Total OcclusionsChronic total occlusions treatment
  468. COMPASS-HFChronicle Offers Management To Patients With Advanced Signs And Symptoms Of Heart Failure
  469. Ciclosporin (oral)Ciclosporin (oral
  470. CircumcisedCircumcision
  471. CircumciseCircumcision
  472. CPVA for Chronic Atrial FibrillationCircumferential Pulmonary Vein Ablation For Chronic Atrial Fibrillation
  473. CATAPULTCisplatin And Tirapazamine In Subjects With Advanced Previously Untreated Non–Small Cell Lung Tumors
  474. CouinaudClaude Couinaud
  475. BETACATHClinical And Angiographic Outcomes After Use Of Sr-90 Beta Radiation For The Treatment Of De Novo And Restenotic Coronary Lesions
  476. CATIEClinical Antipsychotic Trials Of Intervention Effectiveness
  477. NETWORKClinical Outcome With Enalapril In Symptomatic Chronic Heart Failure: A Dose Comparison
  478. COPPAClinical Outcomes From The Prevention Of Postoperative Arrhythmia
  479. VHASClinical Results Of The Verapamil In Hypertension And Atherosclerosis Study
  480. Ddx:DepressionClinical depression
  481. Depression (clinical)Clinical depression
  482. Clinical DepressionClinical depression
  483. Major Depressive DisorderClinical depression
  484. Depressive episodeClinical depression
  485. Recurrent depressive disorderClinical depression
  486. DepressiveClinical depression
  487. Depressive disordersClinical depression
  488. PseudodementiaClinical depression
  489. Unipolar affective disorderClinical depression
  490. MDDClinical depression
  491. CLASS-IHTClomethiazole Acute Stroke Study In Ischemic, Hemorrhagic, And Tpa Treated Stroke
  492. CLASSICSClopidogrel (Plavix) Aspirin Stent International Cooperative Study
  493. PREPAIRClopidogrel 600-Mg Double Loading Dose Achieves Stronger Platelet Inhibition Than Conventional Regimens
  494. CARESSClopidogrel And Aspirin For Reduction Of Emboli In Symptomatic Carotid Stenosis
  495. CLARITY-TIMI 28Clopidogrel As Adjunctive Reperfusion Therapy
  496. PCI CLARITYClopidogrel As Adjunctive Reperfusion Therapy: Percutaneous Coronary Intervention Subgroup Study
  497. CREDOClopidogrel For Reduction Of Events During Observation
  498. CLEAR PLATELETSClopidogrel Loading With Eptifibatide To Arrest The Reactivity Of Platelets Study
  499. CAPRIEClopidogrel Versus Aspirin In Patients At Risk Of Ischemic Events
  500. CLEAR PLATELETS-2Clopidogrel With Eptifibatide To Arrest The Reactivity Of Platelets-2

View (previous 500 | ) (20 | 50 | 100 | 250 | 500)